DOI:
10.1055/s-00000175
Arzneimittelforschung
LinksClose Window
References
Food and Drug Administration/Center for Drug Evaluation and Research (CDER).
Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations.
Washington, DC: Food and Drug Administration; March 2003
We do not assume any responsibility for the contents of the web pages of other providers.